These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1864255)

  • 21. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
    Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutrient imbalances in depressive disorders. Possible brain mechanisms.
    Wurtman RJ; O'Rourke D; Wurtman JJ
    Ann N Y Acad Sci; 1989; 575():75-82; discussion 82-5. PubMed ID: 2699207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
    Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
    Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration].
    Bonin B; Bertschy G; Baumann P; Francois T; Vandel P; Vandel S; Sechter D; Bizouard P
    Encephale; 1996; 22(3):221-7. PubMed ID: 8767051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citalopram concentrations and response in obsessive-compulsive disorder. Preliminary results.
    Bareggi SR; Bianchi L; Cavallaro R; Gervasoni M; Siliprandi F; Bellodi L
    CNS Drugs; 2004; 18(5):329-35. PubMed ID: 15089116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the tolerability and efficacy of citalopram and amitriptyline in elderly depressed patients treated in general practice.
    Kyle CJ; Petersen HE; Overø KF
    Depress Anxiety; 1998; 8(4):147-53. PubMed ID: 9871816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paroxetine and amitriptyline augmentation of lithium in the treatment of major depression: a double-blind study.
    Bauer M; Zaninelli R; Müller-Oerlinghausen B; Meister W
    J Clin Psychopharmacol; 1999 Apr; 19(2):164-71. PubMed ID: 10211918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.
    Nyth AL; Gottfries CG; Lyby K; Smedegaard-Andersen L; Gylding-Sabroe J; Kristensen M; Refsum HE; Ofsti E; Eriksson S; Syversen S
    Acta Psychiatr Scand; 1992 Aug; 86(2):138-45. PubMed ID: 1529737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression.
    Alexopoulos GS; Canuso CM; Gharabawi GM; Bossie CA; Greenspan A; Turkoz I; Reynolds C
    Am J Geriatr Psychiatry; 2008 Jan; 16(1):21-30. PubMed ID: 17928573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Riluzole combination therapy for moderate-to-severe major depressive disorder: A randomized, double-blind, placebo-controlled trial.
    Salardini E; Zeinoddini A; Mohammadinejad P; Khodaie-Ardakani MR; Zahraei N; Zeinoddini A; Akhondzadeh S
    J Psychiatr Res; 2016 Apr; 75():24-30. PubMed ID: 26800392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of serotonergic function in major depression using d-fenfluramine: relation to clinical variables and antidepressant response.
    Cleare AJ; Murray RM; O'Keane V
    Biol Psychiatry; 1998 Oct; 44(7):555-61. PubMed ID: 9787879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.
    Lavretsky H; Park S; Siddarth P; Kumar A; Reynolds CF
    Am J Geriatr Psychiatry; 2006 Feb; 14(2):181-5. PubMed ID: 16473984
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolactin response to fenfluramine and placebo challenge following maintenance pharmacotherapy withdrawal in remitted depressed patients.
    Shapira B; Cohen J; Newman ME; Lerer B
    Biol Psychiatry; 1993 Apr; 33(7):531-5. PubMed ID: 8513038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial.
    Roose SP; Sackeim HA; Krishnan KR; Pollock BG; Alexopoulos G; Lavretsky H; Katz IR; Hakkarainen H;
    Am J Psychiatry; 2004 Nov; 161(11):2050-9. PubMed ID: 15514406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bipolar I and II disorder residual symptoms: oxcarbazepine and carbamazepine as add-on treatment to lithium in a double-blind, randomized trial.
    Juruena MF; Ottoni GL; Machado-Vieira R; Carneiro RM; Weingarthner N; Marquardt AR; Fleig SS; Broilo L; Busnello EA
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):94-9. PubMed ID: 19007842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolactin response to d-fenfluramine in major depression before and after treatment with serotonin reuptake inhibitors.
    Kavoussi RJ; Hauger RL; Coccaro EF
    Biol Psychiatry; 1999 Feb; 45(3):295-9. PubMed ID: 10023505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled study.
    Khajavi D; Farokhnia M; Modabbernia A; Ashrafi M; Abbasi SH; Tabrizi M; Akhondzadeh S
    J Clin Psychiatry; 2012 Nov; 73(11):1428-33. PubMed ID: 23146150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.
    Lavretsky H; Reinlieb M; St Cyr N; Siddarth P; Ercoli LM; Senturk D
    Am J Psychiatry; 2015 Jun; 172(6):561-9. PubMed ID: 25677354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.